• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

BMO FTSE All-Share Tracker 2 Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderBMO Asset Management Limited
Fund SummaryThe Fund aims to achieve capital growth with some income, consistent with the performance of the FTSE All-Share Index. The Fund will invest primarily in equity securities (ordinary shares) that are included in the FTSE All-Share Index by using an optimised portfolio to track the returns of the Index (that is, by purchasing the components that the investment manager believes provide a representative sample in order to replicate the overall performance of the Index). To the extent that the Fund is not fully invested in securities which are included in the Index, the Fund may be invested in shares of companies which in the investment manager’s opinion are reasonably expected to become part of the Index. The Fund may also obtain an indirect exposure to these securities by investing in other transferable securities or collective investment schemes (which may include schemes managed by BMO Global Asset Management) as well as investing in cash and near cash, deposits and money market instruments. The Fund may use derivatives only for the purposes of efficient portfolio management.
SEDOL code0846464
ISINGB0008464645
Fund codeFCFTB
ManagersNot Disclosed
Manager TenureCurrently unavailable
Morningstar CategoryUK Large-Cap Equity
IMA SectorUK All Companies
Fund Size£329 million
Fund TypeOEIC
Management StylePassive
Ongoing Charge Figure (OCF)0.35%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£3.3610
Buy Price£3.3610
Price Change-0.1188%
Price Date30th September 2020
Yield4.50%
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date28th December 2011
Fund StatusOPEN

3-year Mean Monthly Return: -0.145%

Annual Returns201820172016201520142013201220112010
Fund Performance+2.38%+5.45%+12.27%+16.09%-3.17%+5.96%+17.61%+17.58%-5.21%
Benchmark Performance
(UK Large-Cap Equity)
+1.80%+5.06%+11.54%+13.90%
Time PeriodCumulativeBenchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day-0.12%-19.72%+19.60%
1 week-0.94%-1.95%+1.00%
1 month-1.93%-2.53%+0.61%
3 months-3.28%+9.32%-12.60%
6 months8.08%-15.93%+24.01%
1 year-16.64%-3.56%-13.08%
3 years-3.45%+2.72%-6.17%
5 years3.24%+5.01%-1.77%
10 years4.66%+6.78%-2.12%
YTD-19.92%-0.66%-19.26%
Since inceptionCurrently unavailableCurrently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
AstraZeneca PLCGBR5.66%
GlaxoSmithKline PLCGBR3.77%
HSBC Holdings PLCGBR3.45%
Diageo PLCGBR3.00%
British American Tobacco PLCGBR2.97%
BP PLCGBR2.73%
Rio Tinto PLCGBR2.65%
Unilever PLCGBR2.52%
Reckitt Benckiser Group PLCGBR2.45%
Royal Dutch Shell PLC Class AGBR2.35%
Dividend DatePer share amountReinvestment Price
1st May 20200.0554£3.2310
1st November 20190.0879£4.0530
1st May 20190.0779£4.1160
1st November 20180.0799£3.9720
1st May 20180.0717£4.2090
1st November 20170.0757£4.1900